El-Twab Abd,Hussein SM,Hozayen OE,Bin-Jumah WG,Mahmoud AM M .2019 .Chicoric acid prevents methotrexate-induced kidney injury by suppressing NF-κB/NLRP3 inflammasome activation and upregulating Nrf2/ARE/HO-1 signaling. Inflamm. Res., 68(6) : 511-523.
Agus A,Clément K,Sokol H K .2021 .Gut microbiotaderived metabolites as central regulators in metabolic disorders. Gut, 70(6) : 1174-1182.
Bai LL,Zhang LQ,Ma J,Li J,Tian M,Cao RJ,He XX,He ZX,Yu HL,Zhu XJ .2021 .DIP2A is involved in SOD-mediated antioxidative reactions in murine brain. Free. Radic. Biol. Med, 168 : 6-15.
Bollong MJ,Lee G,Coukos JS,Yun H,Zambaldo C,Chang JW,Chin EN,Ahmad I,Chatterjee AK,Lairson LL,Schultz PG,Moellering RE .2018 .A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature, 562(7728) : 600-604.
Cai T,Abel L,Langford O,Monaghan G,Aronson JK,Stevens RJ,Lay-Flurrie S,Koshiaris C,McManus RJ,Hobbs FDR,Sheppard JP .2021 .Associations between statins and adverse events in primary prevention of cardiovascular disease: Systematic review with pairwise, network and dose-response metaanalyses. BMJ, 14(374) : n1537.
Chen S,Wu Y,Qin X,Wen P,Liu J,Yang M .2021 .Global gene expression analysis using RNA-seq reveals the new roles of Panax notoginseng Saponins in ischemic cardiomyocytes. J. Ethnopharmacol., 268 : 113639.
Cheng D,Zhang M,Zheng Y,Wang M,Gao Y,Wang X,Liu X,Lv W,Zeng X,Belosludtsev KN,Su J,Zhao L,Liu J .2024 .α-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1α/Nrf2 pathway. , 74 : 103230.
Cuadrado A,Rojo AI,Wells G,Hayes JD,Cousin SP,Rumsey WL,Attucks OC,Franklin S,Levonen AL,Kensler TW,Dinkova-Kostova AT .2019 .Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat. Rev. Drug Discov, 18(4) : 295-317.
Facchinetti MM .2020 .Heme-Oxygenase-1. , 32(17) : 1239-1242.
Fang QL,Qiao X,Yin XQ,Zeng YC,Du CH,Xue YM,Zhao XJ,Hu CY,Huang F,Lin YP .2023 .Flavonoids from Scutellaria amoena CH Wright alleviate mitochondrial dysfunction and regulate oxidative stress via Keap1/Nrf2/HO-1 axis in rats with high-fat diet-induced nonalcoholic steatohepatitis. Biomed, 158 : 114160.
Frazier K,Manzoor S,Carroll K,DeLeon O,Miyoshi S,Miyoshi J,St George M,Tan A,Chrisler EA,Izumo M,Takahashi JS,Rao MC,Leone VA,Chang EB .2023 .Gut microbes and the liver circadian clock partition glucose and lipid metabolism. J. Clin. Invest, 133(18) : e162515.
Guo YY,Li HX,Zhang Y,He WH Y .2019 .Hypertriglyceridemia-induced acute pancreatitis: Progress on disease mechanisms and treatment modalities. Discov. Med, 27(147) : 101-109.
Han J,Hou J,Liu Y,Liu P,Zhao T,Wang X .2022 .Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the treatment of myocardial fibrosis. J. Diabetes. Res., 8895950 : .
Li T,Jiang S,Lu C,Hu W,Ji T,Han M,Yang Yand Z .2018 .Snapshots: Endoplasmic Reticulum Stress in Lipid Metabolism and Cardiovascular Disease. Curr. Issues. Mol. Biol, 28 : 14-28.
Li X,Li R,Wang X,Zhang X,Xiao Z,Wang H,Sun W,Yang H,Yu P,Hu Q,Guo Q,Sun H Q .2023 .Effects and mechanism of action of Chrysanthemum morifolium (Jinsi Huangju) on hyperlipidemia and nonalcoholic fatty liver disease. Eur. J. Med, 55 : 115391.
Liu J,Jiang C,Ma X,Wang J X .2019 .Notoginsenoside Fc accelerates reendothelialization following vascular injury in diabetic rats by promoting endothelial cell autophagy. J. Diabetes. Res., 9696521 : .
Morita SY .2016 .Metabolism and modification of apolipoprotein B-containing lipoproteins involved in dyslipidemia and atherosclerosis. Biol. Pharm. Bull., 39(1) : 1-24.
Newman CB .2022 .Safety of statins and nonstatins for treatment of dyslipidemia. Endocrinol. Metab. Clin. North. Am., 51(3) : 655-679.
Qu J,Ko CW,Tso P,Bhargava A .2019 .Apolipoprotein A-IV: A multifunctional protein involved in protection against atherosclerosis and diabetes. Cells, 8(4) : 319.
Shen B,Zhao C,Wang Y,Peng Y,Cheng J,Li Z,Wu L,Jin M,Feng H M .2019 .Aucubin inhibited lipid accumulation and oxidative stress via Nrf2/HO-1 and AMPK signalling pathways. J. Cell. Mol. Med, 23(6) : 4063-4075.
Shin NR,Bose S,Choi Y,Kim YM,Chin YW,Song EJ,Nam YD,Kim H YD .2021 .Anti-obesity effect of fermented Panax notoginseng is mediated via modulation of appetite and gut microbial population. Front, 12 : 665881.
Stewart J,McCallin T,Martinez J,Chacko S,Yusuf S S .2020 .. Hyperlipidemia. Pediatr. Rev., 41(8) : 393-402.
Ta N,A L E E,Qi R,Mu X,Feng L,Ba G,Li Y,Zhang J,Bai L,Fu M .2023 .Metabolomics analysis reveals amelioration effects of yellow horn tea extract on hyperlipidemia, inflammation and oxidative stress in high-fat diet-fed mice. Front. Nutr, 10 : 1087256.
Tabas I,Bornfeldt KE .2020 .Intracellular and Intercellular aspects of macrophage immunometabolism in atherosclerosis. Circ. Res., 126(9) : 1209-1227.
Wang Y,Sun X,Xie Y,Du A,Chen M,Lai S,Wei X,Ji L,Wang C .2024 .Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: Association with the NF-κB signaling pathway. J. Ethnopharmacol., 319 : 117135.
Wu S,Yang T,Cen K,Shi X,Zhou D,Gao Y,Chai L,Zhao Y,Sun Y,Zhu L Y .2020 .In vitro Evaluation of the Neuroprotective Effect of Panax notoginseng Saponins by activating the EGFR/PI3K/ AKT Pathway. Evid. Based Complement. Alternat. Med, : 1403572.
Wu Z .2022 .Therapeutic effect of sanqi danshen tablet on viral myocarditis mice through immunomodulation. CABI. Databases, : 1838-1844.
Yamamoto M,Kensler TW,Motohashi H TW .2018 .The KEAP1-NRF2 System: A thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol. Rev., 98(3) : 1169-1203.
Yang H,Liu Z,Hu X,Liu X,Gui L,Cai Z,Dai C .2022 .Protective Effect of Panax Notoginseng saponins on apolipoprotein-E-deficient Atherosclerosis-prone Mice. Curr. Pharm. Des., 28(8) : 671-677.
Yang X,Xiong X,Wang H,Wang J .2014 .Protective effects of panax notoginseng saponins on cardiovascular diseases: A comprehensive overview of experimental studies. Evid. Based. Complement, : 204840.
Zhang B,Zhang J,Zhang C,Zhang X,Ye J,Kuang S,Sun G,Sun X .2018 .Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling. Front. Pharmacol., 9 : 1227.